Imbalance between tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 after cardiopulmonary resuscitation
Jingsha Li(Suzhou University of Science and Technology), Yun Zhang(Baylor College of Medicine), Guoying Su(Ministry of Education of the People's Republic of China), Donglin Liu(Boston University), Jingquan Zhong(Qingdao University), Meng Xiang-lin(Ministry of Education of the People's Republic of China), Hongzhen Liu(Sun Yat-sen University)
Cited by 1
Related Papers
Traditional Chinese Medicine for Cardiovascular Disease
|Journal of the American College of Cardiology|2017|592
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
|Bioconjugate Chemistry|2015|302
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome
|Cardiovascular Research|2021|270
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
|The Lancet Respiratory Medicine|2022|145
Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study
|The Lancet Regional Health - Western Pacific|2022|137